Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
deals
life sciences
national blog main
boston blog main
boston top stories
fda
medical devices
national top stories
startups
alirocumab
alnylam pharmaceuticals
amgen
atrial fibrillation
boston
boston scientific
clinical trial
clinical trials
cryterion medical
detroit
detroit blog main
detroit top stories
evolocumab
food and drug administration
genetic testing
inclisiran
investing
invitae
mergers & acquisitions
millipede
new york
new york blog main
new york top stories
non-invasive prenatal tests
novartis
pcsk9
pcsk9 inhibitors
prenatal tests
regenerative medicine
regeneron pharmaceuticals
What
acquire
4
×
deal
4
×
billion
business
cash
device
medical
ability
adding
adds
agreed
array
atrial
babies
bio
boston
brings
cholesterol
company
compound
continues
cost
cryterion
drug
expand
extremities
fda
fibrillation
genetic
giant
heart
invitae
low
maker
management
medco
medicines
new
novartis
offers
Language
unset
Current search:
deal
×
biotech
×
acquire
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion